Mesa Laboratories, Inc. (MLAB)
134.27
-4.74
(-3.41%)
USD |
NASDAQ |
Nov 16, 16:00
134.27
0.00 (0.00%)
After-Hours: 18:33
Mesa Laboratories Enterprise Value : 907.59M for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 907.59M |
| November 12, 2026 | 886.20M |
| November 11, 2026 | 908.72M |
| November 10, 2026 | 895.80M |
| November 09, 2026 | 844.77M |
| November 06, 2026 | 847.19M |
| November 05, 2026 | 796.94M |
| November 04, 2026 | 835.62M |
| November 03, 2026 | 831.64M |
| November 02, 2026 | 811.93M |
| October 30, 2026 | 844.72M |
| October 29, 2026 | 874.02M |
| October 28, 2026 | 864.42M |
| October 27, 2026 | 852.80M |
| October 26, 2026 | 856.28M |
| October 23, 2026 | 849.49M |
| October 22, 2026 | 851.96M |
| October 21, 2026 | 852.52M |
| October 20, 2026 | 829.84M |
| October 19, 2026 | 819.43M |
| October 16, 2026 | 814.79M |
| October 15, 2026 | 844.32M |
| October 14, 2026 | 835.45M |
| October 13, 2026 | 843.31M |
| October 12, 2026 | 846.18M |
| Date | Value |
|---|---|
| October 09, 2026 | 843.03M |
| October 08, 2026 | 834.89M |
| October 07, 2026 | 856.79M |
| October 06, 2026 | 891.03M |
| October 05, 2026 | 925.67M |
| October 02, 2026 | 871.33M |
| October 01, 2026 | 853.08M |
| September 30, 2026 | 856.67M |
| September 29, 2026 | 863.59M |
| September 28, 2026 | 874.84M |
| September 25, 2026 | 880.72M |
| September 24, 2026 | 900.08M |
| September 23, 2026 | 874.95M |
| September 22, 2026 | 884.02M |
| September 21, 2026 | 868.57M |
| September 18, 2026 | 838.75M |
| September 17, 2026 | 842.11M |
| September 16, 2026 | 831.75M |
| September 15, 2026 | 842.16M |
| September 14, 2026 | 810.43M |
| September 11, 2026 | 807.02M |
| September 10, 2026 | 807.24M |
| September 09, 2026 | 824.03M |
| September 08, 2026 | 823.08M |
| September 04, 2026 | 845.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 51.24B |
| Bio-Rad Laboratories, Inc. | 9.549B |
| Bruker Corp. | 11.01B |
| Danaher Corp. | 186.02B |
| Harvard Bioscience, Inc. | 82.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 4.341M |
| Revenue (Quarterly) | 62.34M |
| Total Expenses (Quarterly) | 58.00M |
| EPS Diluted (Quarterly) | 0.7536 |
| Gross Profit Margin (Quarterly) | 57.36% |
| Profit Margin (Quarterly) | 6.96% |
| Earnings Yield | 0.86% |
| Operating Earnings Yield | 3.44% |
| Normalized Earnings Yield | 0.8576 |